Deutsche Bank’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-2,217,236
| Closed | -$407M | – | 4952 |
|
|
2021
Q2 | $407M | Sell |
2,217,236
-62,309
| -3% | -$10.7M | 0.2% | 115 |
|
|
2021
Q1 | $349M | Buy |
2,279,545
+970,240
| +74% | +$150M | 0.19% | 115 |
|
|
2020
Q4 | $205M | Sell |
1,309,305
-178,594
| -12% | -$22.9M | 0.13% | 165 |
|
|
2020
Q3 | $170M | Buy |
1,487,899
+39,402
| +3% | +$4.25M | 0.12% | 168 |
|
|
2020
Q2 | $163M | Sell |
1,448,497
-35,482
| -2% | -$3.77M | 0.12% | 153 |
|
|
2020
Q1 | $133M | Sell |
1,483,979
-72,825
| -5% | -$7.15M | 0.12% | 165 |
|
|
2019
Q4 | $168M | Buy |
1,556,804
+47,099
| +3% | +$5.04M | 0.11% | 189 |
|
|
2019
Q3 | $148M | Buy |
1,509,705
+100,857
| +7% | +$11.4M | 0.1% | 207 |
|
|
2019
Q2 | $185M | Buy |
1,408,848
+172,787
| +14% | +$22.3M | 0.11% | 195 |
|
|
2019
Q1 | $167M | Buy |
1,236,061
+159,903
| +15% | +$19.9M | 0.1% | 221 |
|
|
2018
Q4 | $105M | Sell |
1,076,158
-349,533
| -25% | -$41.3M | 0.07% | 278 |
|
|
2018
Q3 | $198M | Buy |
1,425,691
+2,317
| +0.2% | +$291K | 0.1% | 215 |
|
|
2018
Q2 | $177M | Sell |
1,423,374
-188,552
| -12% | -$22M | 0.09% | 234 |
|
|
2018
Q1 | $180M | Buy |
1,611,926
+670,469
| +71% | +$80.1M | 0.09% | 232 |
|
|
2017
Q4 | $113M | Buy |
941,457
+290,414
| +45% | +$35.4M | 0.07% | 285 |
|
|
2017
Q3 | $91.3M | Sell |
651,043
-350,783
| -35% | -$47.7M | 0.06% | 344 |
|
|
2017
Q2 | $122M | Buy |
1,001,826
+221,950
| +28% | +$25.8M | 0.09% | 264 |
|
|
2017
Q1 | $94.5M | Buy |
779,876
+201,998
| +35% | +$26M | 0.07% | 318 |
|
|
2016
Q4 | $70.7M | Sell |
577,878
-145,204
| -20% | -$17.8M | 0.06% | 374 |
|
|
2016
Q3 | $88.6M | Buy |
723,082
+71,005
| +11% | +$9.14M | 0.06% | 343 |
|
|
2016
Q2 | $76.1M | Buy |
652,077
+114,379
| +21% | +$16.2M | 0.05% | 392 |
|
|
2016
Q1 | $74.9M | Sell |
537,698
-294,985
| -35% | -$43.3M | 0.06% | 375 |
|
|
2015
Q4 | $159M | Buy |
832,683
+187,023
| +29% | +$32.7M | 0.11% | 217 |
|
|
2015
Q3 | $101M | Buy |
645,660
+29,097
| +5% | +$5.31M | 0.08% | 290 |
|
|
2015
Q2 | $111M | Buy |
616,563
+113,340
| +23% | +$19.6M | 0.07% | 326 |
|
|
2015
Q1 | $87.2M | Buy |
503,223
+13,368
| +3% | +$2.42M | 0.05% | 381 |
|
|
2014
Q4 | $90.6M | Sell |
489,855
-75,515
| -13% | -$14M | 0.06% | 401 |
|
|
2014
Q3 | $93.7M | Sell |
565,370
-131,654
| -19% | -$21.6M | 0.06% | 357 |
|
|
2014
Q2 | $109M | Buy |
697,024
+224,629
| +48% | +$35.5M | 0.07% | 312 |
|
|
2014
Q1 | $71.9M | Sell |
472,395
-82,160
| -15% | -$13.1M | 0.05% | 416 |
|
|
2013
Q4 | $73.7M | Sell |
554,555
-48,319
| -8% | -$5.8M | 0.05% | 392 |
|
|
2013
Q3 | $70M | Sell |
602,874
-94,584
| -14% | -$10.4M | 0.05% | 396 |
|
|
2013
Q2 | $64.3M | Buy |
+697,458
| New | +$67.2M | 0.05% | 383 |
|
Other funds holding ALXN
BCI
NICM
TAIM
RG
CFO
MAM